Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001
Business Overview: The Company operates in the nutritional supplement market through an independent sales force of Managers and Distributors. Operations are segmented geographically into the United States, Latin America, Asia Pacific, and Other regions.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Sales | $81,694 | $81,426 |
| Net Income | $4,022 | $4,496 |
| Operating Income | $6,405 | $6,935 |
| Net Cash from Operating Activities | $10,058 | $10,028 |
| Cash and Cash Equivalents (End of Period) | $33,080 | $26,005 |
| Short-Term Debt | $230 | N/A |
| Basic EPS | $0.25 | $0.26 |
Note: All dollar amounts in thousands except per-share data.
Material Changes vs. Prior Period
- Sales Growth: Sales increased 0.3% to $81.7 million. This was driven by an 11% increase in international sales ($35.7 million), which offset a 7% decline in U.S. sales ($46.0 million) due to increased competition.
- Profitability: Net income decreased 10.5% to $4.0 million. Operating income declined 7.6% to $6.4 million, primarily due to higher SG&A expenses as a percentage of sales and a decrease in other income.
- Segment Performance:
- Asia Pacific: Sales grew 20.2% (driven by South Korea and the Synergy Japan acquisition).
- Latin America: Sales grew 5.8% (driven by Mexico, Venezuela, and Ecuador).
- United States: Sales declined due to product competition and distributor competition.
- Balance Sheet: Accrued volume incentives increased by $2.6 million to $12.4 million, largely due to increased domestic sales in anticipation of a price increase effective April 1, 2001.
Outlook, Risks, and Management Commentary
- Guidance: Management expects cost of goods sold and volume incentives to remain relatively constant as a percent of sales for the remainder of 2001. SG&A expenses are expected to decrease slightly as a percent of sales.
- Liquidity: Cash increased by $4.3 million. Management believes working capital needs can be met through internal funds, though a prolonged economic downturn could impact long-term liquidity. No external credit facilities are currently maintained.
- Capital Projects: A facility expansion project is underway with an estimated total cost of $14.0 million; $4.0 million had been paid as of March 31, 2001. Completion is scheduled for Q2 2002.
- Strategic Agreement: Entered into an agreement with Cetalon Corporation to manufacture a line of herbs and vitamins. This includes acquiring 10% of Cetalon and granting Cetalon a warrant to purchase up to 5% of Nature's Sunshine stock.
- Risks:
- Foreign Currency: Approximately 44% of revenue is international. A strengthening U.S. dollar negatively impacts sales and expenses. The Company does not use derivative instruments for hedging.
- Competition: Strong competition in the U.S. nutritional supplement market is expected to continue.
Investor Verification Checklist
- Verify the sustainability of international sales growth (11% increase) given the 7% decline in the U.S. market.
- Monitor the impact of the April 1, 2001 price increase on future U.S. sales volumes.
- Assess the integration progress and financial contribution of the Synergy Japan acquisition.
- Review the status and funding requirements of the $14.0 million facility expansion project.
- Track foreign currency exchange rate fluctuations, particularly in Brazil, Japan, Mexico, South Korea, and Venezuela, as they significantly impact reported results.